Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-730536
Filing Date
2016-10-04
Accepted
2016-10-04 16:36:02
Documents
2
Effectiveness Date
2016-10-04

Document Format Files

Seq Description Document Type Size
1 DEFA14A d204400ddefa14a.htm DEFA14A 20917
2 GRAPHIC g204400g44c74.gif GRAPHIC 5422
  Complete submission text file 0001193125-16-730536.txt   29671
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-21990 | Film No.: 161919454
SIC: 2836 Biological Products, (No Diagnostic Substances)